4.7 Review

Novel neurosteroid therapeutics for post-partum depression: perspectives on clinical trials, program development, active research, and future directions

Related references

Note: Only part of the references are listed.
Article Neurosciences

Pregnenolone effects on provoked alcohol craving, anxiety, HPA axis, and autonomic arousal in individuals with alcohol use disorder

Verica Milivojevic et al.

Summary: This study suggests that pregnenolone can reduce alcohol and stress-induced craving and normalize HPA axis and autonomic arousal in individuals with alcohol use disorder (AUD). Further assessment of pregnenolone in the treatment of AUD is warranted.

PSYCHOPHARMACOLOGY (2023)

Article Medicine, General & Internal

Brexanolone therapeutics in post-partum depression involves inhibition of systemic inflammatory pathways

Irina Balan et al.

Summary: The study found that brexanolone inhibits proinflammatory modulators and macrophage activation in patients with post-partum depression, which may promote clinical recovery.

EBIOMEDICINE (2023)

Article Psychiatry

Zuranolone for the Treatment of Postpartum Depression

Kristina M. Deligiannidis et al.

Summary: This study investigated the efficacy and safety of Zuranolone, a positive allosteric modulator of GABAA receptors, as an oral treatment for severe postpartum depression. The results demonstrated significant improvements in depressive symptoms and a good tolerability profile for Zuranolone.

AMERICAN JOURNAL OF PSYCHIATRY (2023)

Article Psychology, Clinical

Zuranolone in Major Depressive Disorder: Results From MOUNTAIN-A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial

Anita H. Clayton et al.

Summary: This study evaluated the efficacy and safety of zuranolone in major depressive disorder. Significant improvements in depressive symptoms were observed with zuranolone at days 3, 8, and 12. Zuranolone was generally well tolerated in patients with MDD.

JOURNAL OF CLINICAL PSYCHIATRY (2023)

Editorial Material Neurosciences

Mechanisms Underlying Recovery From Postpartum Depression Following Brexanolone Therapy

A. Leslie Morrow et al.

BIOLOGICAL PSYCHIATRY (2022)

Review Pharmacology & Pharmacy

Advances in pharmacotherapy for postpartum depression: a structured review of standard-of-care antidepressants and novel neuroactive steroid antidepressants

Yardana Kaufman et al.

Summary: Postpartum depression is a common condition that can have negative effects on both the mother and the baby. Standard antidepressants have limited evidence for their safety and efficacy, while new drugs may offer better treatment options. This article reviews the efficacy and safety of various drugs in the treatment of postpartum depression.

THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2022)

Article Immunology

Inhibition of human macrophage activation via pregnane neurosteroid interactions with toll-like receptors: Sex differences and structural requirements

Irina Balan et al.

Summary: The study found that allopregnanolone inhibits TLR4 and TLR7 activation in cultured human macrophages, resulting in reduced cytokine/chemokine production. This inhibition of TLR4 activation was found in both male and female donors, while the inhibition of TLR7 signaling showed specificity for female donors. These findings demonstrate the anti-inflammatory effects of allopregnanolone in human macrophages for the first time, suggesting its therapeutic potential in inhibiting pro-inflammatory cytokines/chemokines.

FRONTIERS IN IMMUNOLOGY (2022)

Article Psychiatry

Neurosteroid allopregnanolone (3α,5α-THP) inhibits inflammatory signals induced by activated MyD88-dependent toll-like receptors

Irina Balan et al.

Summary: The research shows that 3 alpha, 5 alpha-THP inhibits the activation of TLR4, TLR2, and TLR7 signals, but not TLR3 signal, by blocking the TLR-MyD88 interaction. This inhibition leads to decreased production of pro-inflammatory mediators and supports the potential therapeutic use of 3 alpha, 5 alpha-THP for inflammatory diseases.

TRANSLATIONAL PSYCHIATRY (2021)

Article Psychiatry

Effect of Zuranolone vs Placebo in Postpartum Depression A Randomized Clinical Trial

Kristina M. Deligiannidis et al.

Summary: Zuranolone demonstrated significant improvements in core symptoms of depression in women with postpartum depression (PPD) and was generally well tolerated, supporting further development of zuranolone as a treatment for PPD.

JAMA PSYCHIATRY (2021)

Article Neurosciences

Allopregnanolone in postpartum depression: Role in pathophysiology and treatment

Samantha Meltzer-Brody et al.

NEUROBIOLOGY OF STRESS (2020)

Article Public, Environmental & Occupational Health

Perinatal mood and anxiety disorders, serious mental illness, and delivery-related health outcomes, United States, 2006-2015

Kimberly McKee et al.

BMC WOMENS HEALTH (2020)

Review Endocrinology & Metabolism

Toll-Like Receptor Signaling in Depression

Leandra K. Figueroa-Hall et al.

PSYCHONEUROENDOCRINOLOGY (2020)

Review Immunology

Toll-like receptors in immunity and inflammatory diseases: Past, present, and future

Kumar Vijay

INTERNATIONAL IMMUNOPHARMACOLOGY (2018)

Article Medicine, General & Internal

Postpartum psychiatric disorders

Samantha Meltzer-Brody et al.

NATURE REVIEWS DISEASE PRIMERS (2018)

Article Psychology, Developmental

Maternal Depressive Symptoms During and After Pregnancy and Psychiatric Problems in Children

Marius Lahti et al.

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2017)

Article Medicine, General & Internal

Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial

Stephen Kanes et al.

LANCET (2017)

Article Biochemistry & Molecular Biology

Crystal structures of a GABAA-receptor chimera reveal new endogenous neurosteroid-binding sites

Duncan Laverty et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)

Article Neurosciences

A randomized controlled trial of ganaxolone in posttraumatic stress disorder

Ann M. Rasmusson et al.

PSYCHOPHARMACOLOGY (2017)

Review Psychiatry

Impact of Postpartum Mental Illness Upon Infant Development

Casey Hoffman et al.

CURRENT PSYCHIATRY REPORTS (2017)

Article Biochemistry & Molecular Biology

Crystal structures of a GABAA-receptor chimera reveal new endogenous neurosteroid-binding sites

Duncan Laverty et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)

Article Psychology, Clinical

The Perinatal Depression Treatment Cascade: Baby Steps Toward Improving Outcomes

Elizabeth Q. Cox et al.

JOURNAL OF CLINICAL PSYCHIATRY (2016)

Review Neurosciences

Role of neuro-immunological factors in the pathophysiology of mood disorders

Anindya Bhattacharya et al.

PSYCHOPHARMACOLOGY (2016)

Article Neurosciences

A Randomized, Double-Blind, Placebo-Controlled Trial of Pregnenolone for Bipolar Depression

E. Sherwood Brown et al.

NEUROPSYCHOPHARMACOLOGY (2014)

Article Endocrinology & Metabolism

New insights into the role of perinatal HPA-axis dysregulation in postpartum depression

Laura M. Glynn et al.

NEUROPEPTIDES (2013)

Review Endocrinology & Metabolism

Inflammation-associated depression: From serotonin to kynurenine

Robert Dantzer et al.

PSYCHONEUROENDOCRINOLOGY (2011)

Review Neurosciences

Toll-like receptor signaling in neural plasticity and disease

Eitan Okun et al.

TRENDS IN NEUROSCIENCES (2011)

Article Neurosciences

A Meta-Analysis of Cytokines in Major Depression

Yekta Dowlati et al.

BIOLOGICAL PSYCHIATRY (2010)

Review Psychology, Developmental

Postpartum depression effects on early interactions, parenting, and safety practices: A review

Tiffany Field

INFANT BEHAVIOR & DEVELOPMENT (2010)

Article Biochemistry & Molecular Biology

Estrogen Inhibits Glucocorticoid Action via Protein Phosphatase 5 (PP5)-mediated Glucocorticoid Receptor Dephosphorylation

Yong Zhang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Review Public, Environmental & Occupational Health

The Prevalence of Postpartum Depression among Women with Substance Use, an Abuse History, or Chronic Illness: A Systematic Review

Lori E. Ross et al.

JOURNAL OF WOMENS HEALTH (2009)

Review Psychiatry

Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis

M. Bryant Howren et al.

PSYCHOSOMATIC MEDICINE (2009)

Article Psychiatry

Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression

PJ Schmidt et al.

ARCHIVES OF GENERAL PSYCHIATRY (2005)

Review Psychiatry

Endocrine factors in the etiology of postpartum depression

M Bloch et al.

COMPREHENSIVE PSYCHIATRY (2003)

Review Medicine, General & Internal

Placebo response in studies of major depression - Variable, substantial, and growing

BT Walsh et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)

Article Psychiatry

Effects of gonadal steroids in women with a history of postpartum depression

M Bloch et al.

AMERICAN JOURNAL OF PSYCHIATRY (2000)